can semaglutide raise liver enzymes Focus on 2.4 mg/week for the Treatment of Metabolic Dysfunction‐Associated Steatohepatitis Semaglutide Injection Protocol for Medical

M., Demaria M., Rathod S., Vasserot A

No published study has demonstrated this, but the question remains open (Crockford et al., Ann N Y Acad Sci 2010)

Dehydration represents an important factor, as GLP-1 medications can cause nausea, vomiting, and diarrhea, particularly during dose escalation, leading to volume depletion

When pharmacotherapy does not adequately control the disease, metabolic surgery remains the most effective, durable, and evidence-based treatment, with proven long-term benefits on metabolic health, comorbidities, and survival

No clinical trials have validated the specific MIC injection formulation for weight loss in humans